Alirocumab
id:
alirocumab-299-11274179
title:
Alirocumab
text:
Alirocumab, sold under the brand name Praluent, is a medication used as a second-line treatment for high cholesterol for adults whose cholesterol is not controlled by diet and statin treatment. It is a human monoclonal antibody that belongs to a novel class of anti-cholesterol drugs, known as PCSK9 inhibitors, and it was the first such agent to receive FDA approval. The FDA approval was contingent on the completion of further clinical trials to better determine efficacy and safety. Common side e
brand slug:
wiki
category slug:
encyclopedia
description:
Pharmaceutical drug
original url:
https://en.wikipedia.org/wiki/Alirocumab
date created:
date modified:
2024-04-07T05:22:48Z
main entity:
{"identifier":"Q4726914","url":"https://www.wikidata.org/entity/Q4726914"}
image:
fields total:
13
integrity:
14